IS7561A - Samsett afurð sem felur í sér melagatran og sláttarglapastillandi oxabispíden - Google Patents

Samsett afurð sem felur í sér melagatran og sláttarglapastillandi oxabispíden

Info

Publication number
IS7561A
IS7561A IS7561A IS7561A IS7561A IS 7561 A IS7561 A IS 7561A IS 7561 A IS7561 A IS 7561A IS 7561 A IS7561 A IS 7561A IS 7561 A IS7561 A IS 7561A
Authority
IS
Iceland
Prior art keywords
oxabispidene
antiaircraft
melagatran
compound product
compound
Prior art date
Application number
IS7561A
Other languages
English (en)
Inventor
Svernhage Elisabeth
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS7561A publication Critical patent/IS7561A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS7561A 2002-05-06 2004-11-29 Samsett afurð sem felur í sér melagatran og sláttarglapastillandi oxabispíden IS7561A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201373A SE0201373D0 (sv) 2002-05-06 2002-05-06 Combination therapy
PCT/SE2003/000720 WO2003092721A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes

Publications (1)

Publication Number Publication Date
IS7561A true IS7561A (is) 2004-11-29

Family

ID=20287788

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7561A IS7561A (is) 2002-05-06 2004-11-29 Samsett afurð sem felur í sér melagatran og sláttarglapastillandi oxabispíden

Country Status (19)

Country Link
US (1) US20060074080A1 (is)
EP (1) EP1503782A1 (is)
JP (1) JP2005531546A (is)
KR (1) KR20050007470A (is)
CN (1) CN1652811A (is)
AR (1) AR039572A1 (is)
AU (1) AU2003224590A1 (is)
BR (1) BR0309354A (is)
CA (1) CA2483001A1 (is)
IL (1) IL164869A0 (is)
IS (1) IS7561A (is)
MX (1) MXPA04010716A (is)
NO (1) NO20044554L (is)
PL (1) PL372368A1 (is)
RU (1) RU2004129730A (is)
SE (1) SE0201373D0 (is)
TW (1) TW200403071A (is)
WO (1) WO2003092721A1 (is)
ZA (1) ZA200408615B (is)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor

Also Published As

Publication number Publication date
WO2003092721A1 (en) 2003-11-13
TW200403071A (en) 2004-03-01
PL372368A1 (en) 2005-07-25
JP2005531546A (ja) 2005-10-20
BR0309354A (pt) 2005-02-15
SE0201373D0 (sv) 2002-05-06
US20060074080A1 (en) 2006-04-06
ZA200408615B (en) 2006-04-26
IL164869A0 (en) 2005-12-18
RU2004129730A (ru) 2005-07-10
MXPA04010716A (es) 2005-03-07
KR20050007470A (ko) 2005-01-18
CA2483001A1 (en) 2003-11-13
CN1652811A (zh) 2005-08-10
AU2003224590A1 (en) 2003-11-17
NO20044554L (no) 2004-11-16
AR039572A1 (es) 2005-02-23
EP1503782A1 (en) 2005-02-09

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
IS7434A (is) N-amínóasetýl-pýrrólídín-2-karbónítríl og notkun þeirra sem DDP-IV tálma
EP1472536A4 (en) VERSATILE INHIBITORS
EP1532133A4 (en) NF-: B INHIBITORS
GB0214658D0 (en) Clasp
GB0220385D0 (en) Compound and process
PL397821A1 (pl) Związek1-acetylo-6-fluoro-2-indolinon
GB0204241D0 (en) Compound
EP1506778A4 (en) TGF-a EXPRESSION INHIBITORS
IL163935A0 (en) Plasma carboxypeptidase b inhibitors
AU2003296960A1 (en) Peptide deformylase inhibitors
GB0224830D0 (en) Compound
GB0204392D0 (en) Pharmaceutical compound
AU2003274059A8 (en) Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof
GB0213027D0 (en) Compound
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
EP1584819A4 (en) COMPRESSOR
GB0211751D0 (en) Compound and process
GB0211196D0 (en) Flood defence
AU2003245423A1 (en) Peptide deformylase inhibitors
AU2003215235A8 (en) Cks1 inhibitors
GB0217330D0 (en) Inhibitors
GB0226149D0 (en) Inhibitors
GB0208094D0 (en) Inhibitors